MSF bio lab at MSF’s Aden hospital controls and treats the anti-resistant infected cases. Aden-The Bio lab project was launched as part of the medical lab at MSF Aden hospital southern Yemen, on January 2017. Photograph by Ehab Zawati/MSF
Technical brief |

Ensuring Collective Efforts Deliver Equitable Access Through the WHO PABS System

MSF recommendations on WHO Pathogen Access and Benefit-Sharing (PABS) systems

PANDEMIC PREPAREDNESS
Read more
Photograph by Ehab Zawati/MSF
Every three minutes, a child dies of tuberculosis (TB), even though treatment is available. In children, under-diagnosis is a major obstacle to effective treatment. New WHO recommendations, including treatment decision algorithms, could change all that. Photo Credit: Stuart Tibaweswa
Press release |

MSF findings show WHO algorithms could double the number of children diagnosed and treated for TB

Governments must act now to ensure no child is left behind in the fight against this deadly disease

TUBERCULOSIS
Read more
Photo Credit: Stuart Tibaweswa
Panel discussion in Brussels on how to improve the availability and affordability of TB medicines in the EU and EEA region. Shailly Gupta/MSF
Press release |

MSF urges EU and EEA to put TB back on the health agenda

Countries in the region must take urgent steps to guarantee effective treatment for all 

TUBERCULOSIS
Europe
Read more
Shailly Gupta/MSF

Latest News

What good is a breakthrough medicine if the people who need it can't afford it?

Video thumbnail
Lives Over Profit: a Patient, a Doctor and a Lawyer Take Action
Video thumbnail
100 years of insulin
Video thumbnail
A Snapshot of the Access Campaign

Our work

COVID-19
Drug-resistant infections
Diabetes
Hepatitis C
HIV/AIDS
Tropical & neglected diseases
Tuberculosis
Vaccines
Patents & intellectual property
Research & development